Lance Cassell, MD
Pain Medicine · Sarasota, FLNPI 1205058328
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 111 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $817 and has fallen 70.9% since, to $238 in 2025. That places this record below the midpoint for pain medicine clinicians in FL, where the typical reported total is $2,085.
Across 111 payments — averaging $18.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$492
- Boston Scientific$306
- Pfizer$181
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$144
- Protega Pharmaceutials Inc$107
- Tersera Therapeutics LLC$85
- plus $762 from 25 others
What the payments were for
- Food & beverage$2,077100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 25 | $492 |
| Boston Scientific | 5 | $306 |
| Pfizer | 18 | $181 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $144 |
| Protega Pharmaceutials Inc | 5 | $107 |
| Tersera Therapeutics LLC | 5 | $85 |
| AbbVie | 4 | $69 |
| GRT US Holding, Inc. | 1 | $56 |
| Kaleo, Inc. | 4 | $55 |
| IBSA Pharma Inc. | 3 | $53 |
| Redhill Biopharma Inc. | 3 | $51 |
| Scilex Pharmaceuticals Inc. | 2 | $42 |
| Amgen | 2 | $42 |
| Daiichi Sankyo Inc. | 3 | $40 |
| Assertio Therapeutics, Inc. | 2 | $39 |
| AstraZeneca | 2 | $35 |
| MDD US Operations, LLC | 2 | $25 |
| Convatec Inc. | 1 | $24 |
| Biodelivery Sciences International, Inc. | 2 | $24 |
| Relievant Medsystems, Inc. | 1 | $22 |
| West Therapeutics Development, LLC | 1 | $21 |
| Electronic Waveform Lab, Inc. | 2 | $19 |
| Avanos Medical | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $19 |
| Novartis | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Nalu Medical, Inc. | 1 | $15 |
| Curonix LLC | 1 | $15 |
| Fidia Pharma USA Inc. | 1 | $15 |
| Hikma Pharmaceuticals USA | 1 | $13 |
| Zyla Life Sciences, Inc. | 1 | $12 |
How this compares
$2,077 in reported general payments places this provider in the 45th percentile of 596 pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 146 | $4,307 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 196 | $4,039 |
| Pregabalin | 45 | $1,878 |
| Gabapentin | 75 | $920 |
| Oxycodone Hcl | 63 | $760 |
| Tramadol Hcl | 88 | $653 |
| Tizanidine Hcl | 46 | $476 |
| Morphine Sulfate ErMorphine Sulfate | 26 | $429 |
| Celecoxib | 13 | $289 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 16 | $285 |
| Methylprednisolone | 41 | $271 |
| Duloxetine Hcl | 21 | $232 |
| Cyclobenzaprine Hcl | 27 | $230 |
| Amitriptyline Hcl | 13 | $160 |
| Omeprazole | 152 | $156 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Sarasota
- Jeffrey GudinMiami$356K
- Joseph PergolizziNaples$333K
- Ramon Cuevas-TrisanRiviera Beach$220K
- Navdeep JassalLakeland$163K
- Mark-Friedrich HurdleJacksonville$140K
- Rodolfo GariTampa$120K
- Stephen PylesOcala$115K
- Orlando FloreteJacksonville$86K
- Michael GreeneMiddleburg$73K
- Nicholas BremerFernandina Beach$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.